Atlas Trials

Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma

Clinical trial NCT03323710 · WITHDRAWN

Trial details

NCT number
NCT03323710
Sponsor
Military Institute od Medicine National Research Institute
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2018-09-01
Primary completion
2019-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.